Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.

Walti, Laura N; Mugglin, Catrina; Sidler, Daniel; Mombelli, Matteo; Manuel, Oriol; Hirsch, Hans H; Khanna, Nina; Mueller, Nicolas; Berger, Christoph; Boggian, Katia; Garzoni, Christian; Neofytos, Dionysios; van Delden, Christian; Hirzel, Cédric

Walti, Laura N; Mugglin, Catrina; Sidler, Daniel; Mombelli, Matteo; Manuel, Oriol; Hirsch, Hans H; Khanna, Nina; Mueller, Nicolas; Berger, Christoph; Boggian, Katia; Garzoni, Christian; Neofytos, Dionysios; van Delden, Christian; Hirzel, Cédric.

Afiliação

Walti LN; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Mugglin C; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Sidler D; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Mombelli M; Transplantation Center and Service of Infectious Diseases, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Manuel O; Transplantation Center and Service of Infectious Diseases, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Hirsch HH; Division of Infectious Diseases and Hospital Epidemiology, University and University Hospital of Basel, Basel, Switzerland.
Khanna N; Division of Infectious Diseases and Hospital Epidemiology, University and University Hospital of Basel, Basel, Switzerland.
Mueller N; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University Zurich, Zurich, Switzerland.
Berger C; Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland.
Boggian K; Division of Infectious Diseases and Hospital Hygiene, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese, Lugano, Switzerland.
Neofytos D; Transplant Infectious Diseases Unit, Faculty of Medicine, University Hospitals of Geneva, Geneva, Switzerland.
van Delden C; Transplant Infectious Diseases Unit, Faculty of Medicine, University Hospitals of Geneva, Geneva, Switzerland.
Hirzel C; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Am J Transplant ; 21(7): 2532-2542, 2021 07.

Article em En | MEDLINE | ID: mdl-33289340

Assuntos

Infecções por Vírus Epstein-Barr; Transtornos Linfoproliferativos; Antivirais/uso terapêutico; Estudos de Coortes; Infecções por Vírus Epstein-Barr/tratamento farmacológico; Herpesvirus Humano 4; Humanos; Transtornos Linfoproliferativos/tratamento farmacológico; Transtornos Linfoproliferativos/etiologia; Transtornos Linfoproliferativos/prevenção & controle; Rituximab/uso terapêutico

Palavras-chave

clinical research/practice; complication: infectious; hematology/oncology; immunosuppressant -fusion proteins and monoclonal antibodies: B cell specific; infection and infectious agents - viral; infection and infectious agents - viral: Epstein-Barr Virus (EBV); infectious disease; posttransplant lymphoproliferative disorder (PTLD)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Vírus Epstein-Barr / Transtornos Linfoproliferativos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google